Vitamin B6 and derivatives. II—13C NMR study of systems formed by pyridoxal phosphate or pyridoxal with octopamine

1980 ◽  
Vol 14 (1) ◽  
pp. 45-48 ◽  
Author(s):  
Raymond Haran ◽  
Jean-Pierre Laurent ◽  
Michel Massol ◽  
Francoise Nepveu-Juras
1982 ◽  
Vol 257 (19) ◽  
pp. 11305-11314 ◽  
Author(s):  
J W Dillwith ◽  
J H Nelson ◽  
J G Pomonis ◽  
D R Nelson ◽  
G J Blomquist

1992 ◽  
Vol 267 (16) ◽  
pp. 11168-11175
Author(s):  
M.R. Soma ◽  
M.P. Mims ◽  
M.V. Chari ◽  
D Rees ◽  
J.D. Morrisett

2021 ◽  
Vol 22 (7) ◽  
pp. 3634
Author(s):  
Beata Szefler ◽  
Przemysław Czeleń ◽  
Przemysław Krawczyk

Platinum compounds have found wide application in the treatment of various types of cancer and carboplatin is one of the main platinum-based drugs used as antitumor agents. The anticancer activity of carboplatin arises from interacting with DNA and inducing programmed cell death. However, such interactions may occur with other chemical compounds, such as vitamins containing aromatic rings with lone-pair orbitals, which reduces the anti-cancer effect of carboplatin. The most important aspect of the conducted research was related to the evaluation of carboplatin affinity to vitamins from the B group and the potential impact of such interactions on the reduction of therapeutic capabilities of carboplatin in anticancer therapy. Realized computations, including estimation of Gibbs Free Energies, allowed for the identification of the most reactive molecule, namely vitamin B6 (pyridoxal phosphate). In this case, the computational estimations indicating carboplatin reactivity were confirmed by spectrophotometric measurements.


1987 ◽  
Vol 25 (3) ◽  
pp. 121-126 ◽  
Author(s):  
Mitsuo Takai ◽  
Keiji Fukuda ◽  
Jisuke Hayashi

ChemInform ◽  
1989 ◽  
Vol 20 (32) ◽  
Author(s):  
K. KAMIENSKA-TRELA ◽  
Z. BIEDRZYCKA ◽  
R. MACHINEK ◽  
W. LUETTKE

Sign in / Sign up

Export Citation Format

Share Document